{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T04:18:21Z","timestamp":1791346701814,"version":"4.3.1"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T00:00:00Z","timestamp":1730592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Fred and Suzanne Biesecker Liver Center at the Children\u2019s Hospital of Philadelphia"},{"DOI":"10.13039\/100008538","name":"PSC Partners Seeking a Cure","doi-asserted-by":"publisher","award":["72-12"],"award-info":[{"award-number":["72-12"]}],"id":[{"id":"10.13039\/100008538","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003977","name":"The Israeli Science Foundation","doi-asserted-by":"crossref","award":["1879\/21"],"award-info":[{"award-number":["1879\/21"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-78387-2","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T13:02:04Z","timestamp":1730638924000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Oral N-acetylcysteine ameliorates liver fibrosis and enhances regenerative responses in Mdr2 knockout mice"],"prefix":"10.1038","volume":"14","author":[{"given":"Adi","family":"Har-Zahav","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Tobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Fried","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Sivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Wilkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raanan","family":"Shamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca G.","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gurevich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orith","family":"Waisbourd-Zinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,3]]},"reference":[{"key":"78387_CR1","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/s41575-019-0125-y","volume":"16","author":"JM Banales","year":"2019","unstructured":"Banales, J. M. et al. Cholangiocyte pathobiology. Nat. Rev. Gastroenterol. Hepatol. 16, 269\u2013281 (2019).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"78387_CR2","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.mayocp.2015.03.017","volume":"90","author":"KN Lazaridis","year":"2015","unstructured":"Lazaridis, K. N. & LaRusso, N. F. The cholangiopathies. Mayo Clin. Proc. 90, 791\u2013800 (2015).","journal-title":"Mayo Clin. Proc."},{"key":"78387_CR3","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ebiom.2018.08.024","volume":"35","author":"PKH Tam","year":"2018","unstructured":"Tam, P. K. H., Yiu, R. S., Lendahl, U. & Andersson, E. R. Cholangiopathies\u2014towards a molecular understanding. EBioMedicine. 35, 381\u2013393 (2018).","journal-title":"EBioMedicine"},{"key":"78387_CR4","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1053\/j.gastro.2004.04.009","volume":"127","author":"P Fickert","year":"2004","unstructured":"Fickert, P. et al. Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. Gastroenterology. 127, 261\u2013274 (2004).","journal-title":"Gastroenterology"},{"key":"78387_CR5","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jhep.2014.02.006","volume":"60","author":"P Fickert","year":"2014","unstructured":"Fickert, P. et al. Characterization of animal models for primary sclerosing cholangitis (PSC). J. Hepatol. 60, 1290\u20131303 (2014).","journal-title":"J. Hepatol."},{"key":"78387_CR6","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.jhep.2017.07.022","volume":"67","author":"TH Karlsen","year":"2017","unstructured":"Karlsen, T. H., Folseraas, T., Thorburn, D. & Vesterhus, M. Primary sclerosing cholangitis\u2014a comprehensive review. J. Hepatol. 67, 1298\u20131323 (2017).","journal-title":"J. Hepatol."},{"key":"78387_CR7","doi-asserted-by":"publisher","first-page":"246","DOI":"10.2174\/1573403X14666180926100811","volume":"15","author":"G Hashemi","year":"2019","unstructured":"Hashemi, G. et al. A pilot study to evaluate the effects of oral N-acetyl cysteine on inflammatory and oxidative stress biomarkers in rheumatoid arthritis. Curr. Rheumatol. Rev. 15, 246\u2013253 (2019).","journal-title":"Curr. Rheumatol. Rev."},{"key":"78387_CR8","unstructured":"WHO model list. of essential medicines\u201422nd list. https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2021.02 (2021)."},{"key":"78387_CR9","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1002\/hep.28599","volume":"64","author":"O Waisbourd-Zinman","year":"2016","unstructured":"Waisbourd-Zinman, O. et al. The toxin biliatresone causes mouse extrahepatic cholangiocyte damage and fibrosis through decreased glutathione and SOX17. Hepatology. 64, 880\u2013893 (2016).","journal-title":"Hepatology"},{"key":"78387_CR10","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00000478-200303000-00008","volume":"27","author":"N Katabi","year":"2003","unstructured":"Katabi, N. & Albores-Saavedra, J. The extrahepatic bile duct lesions in end-stage primary sclerosing cholangitis. Am. J. Surg. Pathol. 27, 349\u2013355 (2003).","journal-title":"Am. J. Surg. Pathol."},{"key":"78387_CR11","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1002\/hep.20600","volume":"41","author":"GK Michalopoulos","year":"2005","unstructured":"Michalopoulos, G. K., Barua, L. & Bowen, W. C. Transdifferentiation of rat hepatocytes into biliary cells after bile duct ligation and toxic biliary injury. Hepatology. 41, 535\u2013544 (2005).","journal-title":"Hepatology"},{"key":"78387_CR12","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1016\/j.jhep.2023.12.023","volume":"80","author":"TS Andrews","year":"2024","unstructured":"Andrews, T. S. et al. Single-cell, single-nucleus, and spatial transcriptomics characterization of the immunological landscape in the healthy and PSC human liver. J. Hepatol. 80, 730\u2013743 (2024).","journal-title":"J. Hepatol."},{"key":"78387_CR13","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1136\/gut.2005.064477","volume":"54","author":"G Nowak","year":"2005","unstructured":"Nowak, G. et al. Identification of expandable human hepatic progenitors which differentiate into mature hepatic cells in vivo. Gut. 54, 972\u2013979 (2005).","journal-title":"Gut"},{"key":"78387_CR14","doi-asserted-by":"crossref","unstructured":"Li, H. et al. Identification of phenotypically, functionally, and anatomically distinct stromal niche populations in human bone marrow based on single-cell RNA sequencing. eLife 12 (2023).","DOI":"10.7554\/eLife.81656"},{"key":"78387_CR15","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.stemcr.2017.06.003","volume":"9","author":"B Li","year":"2017","unstructured":"Li, B. et al. Adult mouse liver contains two distinct populations of cholangiocytes. Stem Cell. Rep. 9, 478\u2013489 (2017).","journal-title":"Stem Cell. Rep."},{"key":"78387_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/cdd.2017.169","volume":"25","author":"BJ Aubrey","year":"2018","unstructured":"Aubrey, B. J., Kelly, G. L., Janic, A., Herold, M. J. & Strasser, A. How does p53 induce apoptosis and how does this relate to p53-mediated tumour suppression? Cell. Death Differ. 25, 104\u2013113 (2018).","journal-title":"Cell. Death Differ."},{"key":"78387_CR17","doi-asserted-by":"publisher","first-page":"841065","DOI":"10.3389\/fimmu.2022.841065","volume":"13","author":"H Hamade","year":"2022","unstructured":"Hamade, H. et al. BATF3 protects against metabolic syndrome and maintains intestinal epithelial homeostasis. Front. Immunol. 13, 841065 (2022).","journal-title":"Front. Immunol."},{"key":"78387_CR18","doi-asserted-by":"crossref","unstructured":"Komposch, K. & Sibilia, M. EGFR signaling in liver diseases. Int. J. Mol. Sci. 17 (2015).","DOI":"10.3390\/ijms17010030"},{"key":"78387_CR19","doi-asserted-by":"crossref","unstructured":"de Collin, A., Gilgenkrantz, H. & Guidotti, J. E. EGFR: A master piece in G1\/S phase transition of liver regeneration. Int. J. Hepatol. 2012, 476910 (2012).","DOI":"10.1155\/2012\/476910"},{"key":"78387_CR20","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00535-013-0907-x","volume":"49","author":"C Berasain","year":"2014","unstructured":"Berasain, C. & Avila, M. A. The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis. J. Gastroenterol. 49, 9\u201323 (2014).","journal-title":"J. Gastroenterol."},{"key":"78387_CR21","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00251-024-01335-x","volume":"76","author":"R Dabbaghipour","year":"2024","unstructured":"Dabbaghipour, R. et al. Concise review: the heterogenous roles of BATF3 in cancer oncogenesis and dendritic cells and T cells differentiation and function considering the importance of BATF3-dependent dendritic cells. Immunogenetics. 76, 75\u201391 (2024).","journal-title":"Immunogenetics"},{"key":"78387_CR22","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.cotox.2017.11.002","volume":"7","author":"K Lingappan","year":"2018","unstructured":"Lingappan, K. NF-\u03baB in oxidative stress. Curr. Opin. Toxicol. 7, 81\u201386 (2018).","journal-title":"Curr. Opin. Toxicol."},{"key":"78387_CR23","doi-asserted-by":"publisher","first-page":"124832","DOI":"10.1016\/j.ijbiomac.2023.124832","volume":"242","author":"AA Bhat","year":"2023","unstructured":"Bhat, A. A. et al. The pyroptotic role of Caspase-3\/GSDME signalling pathway among various cancer: a review. Int. J. Biol. Macromol. 242, 124832 (2023).","journal-title":"Int. J. Biol. Macromol."},{"key":"78387_CR24","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1002\/bab.2233","volume":"69","author":"M Asadi","year":"2022","unstructured":"Asadi, M. et al. Caspase-3: structure, function, and biotechnological aspects. Biotechnol. Appl. Biochem. 69, 1633\u20131645 (2022).","journal-title":"Biotechnol. Appl. Biochem."},{"key":"78387_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/sj.cdd.4400476","volume":"6","author":"AG Porter","year":"1999","unstructured":"Porter, A. G. & J\u00e4nicke, R. U. Emerging roles of caspase-3 in apoptosis. Cell. Death Differ. 6, 99\u2013104 (1999).","journal-title":"Cell. Death Differ."},{"key":"78387_CR26","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jhep.2009.12.005","volume":"52","author":"Y Ju","year":"2010","unstructured":"Ju, Y. et al. T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 52, 322\u2013329 (2010).","journal-title":"J. Hepatol."},{"key":"78387_CR27","doi-asserted-by":"publisher","first-page":"e12825","DOI":"10.1111\/sji.12825","volume":"91","author":"L Zhao","year":"2020","unstructured":"Zhao, L., Yu, G., Han, Q., Cui, C. & Zhang, B. TIM-3: an emerging target in the liver diseases. Scand. J. Immunol. 91, e12825 (2020).","journal-title":"Scand. J. Immunol."},{"key":"78387_CR28","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1182\/blood-2011-11-392951","volume":"119","author":"LC Ndhlovu","year":"2012","unstructured":"Ndhlovu, L. C. et al. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood. 119, 3734\u20133743 (2012).","journal-title":"Blood"},{"key":"78387_CR29","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/eji.200324336","volume":"34","author":"I Jomantaite","year":"2004","unstructured":"Jomantaite, I. et al. Hepatic dendritic cell subsets in the mouse. Eur. J. Immunol. 34, 355\u2013365 (2004).","journal-title":"Eur. J. Immunol."},{"key":"78387_CR30","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/j.1432-0436.2005.00019.x","volume":"73","author":"S Nava","year":"2005","unstructured":"Nava, S. et al. Characterization of cells in the developing human liver. Differentiation. 73, 249\u2013260 (2005).","journal-title":"Differentiation"},{"key":"78387_CR31","doi-asserted-by":"crossref","unstructured":"Freitas-Lopes, M. A., Mafra, K., David, B. A., Carvalho-Gontijo, R. & Menezes, G. B. Differential location and distribution of hepatic immune cells. Cells. 6 (2017).","DOI":"10.3390\/cells6040048"},{"key":"78387_CR32","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ajpath.2014.10.013","volume":"185","author":"N Ikenaga","year":"2015","unstructured":"Ikenaga, N. et al. A new Mdr2(-\/-) mouse model of sclerosing cholangitis with rapid fibrosis progression, early-onset portal hypertension, and liver cancer. Am. J. Pathol. 185, 325\u2013334 (2015).","journal-title":"Am. J. Pathol."},{"key":"78387_CR33","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2460\/ajvr.80.1.74","volume":"80","author":"T Boullhesen-Williams","year":"2019","unstructured":"Boullhesen-Williams, T. et al. In vitro effect of 20% N-acetylcysteine on the viscosity of normal canine bile. Am. J. Vet. Res. 80, 74\u201378 (2019).","journal-title":"Am. J. Vet. Res."},{"key":"78387_CR34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12944-020-01274-y","volume":"19","author":"CC Tsai","year":"2020","unstructured":"Tsai, C. C. et al. Long term N-acetylcysteine administration rescues liver steatosis via endoplasmic reticulum stress with unfolded protein response in mice. Lipids Health Dis. 19, 105 (2020).","journal-title":"Lipids Health Dis."},{"key":"78387_CR35","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1097\/MEG.0b013e32831f1f3a","volume":"21","author":"M Galicia-Moreno","year":"2009","unstructured":"Galicia-Moreno, M. et al. N-acetylcysteine prevents carbon tetrachloride-induced liver cirrhosis: role of liver transforming growth factor-beta and oxidative stress. Eur. J. Gastroenterol. Hepatol. 21, 908\u2013914 (2009).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"78387_CR36","doi-asserted-by":"publisher","first-page":"23","DOI":"10.4149\/gpb_2017016","volume":"37","author":"O Otrubov\u00e1","year":"2018","unstructured":"Otrubov\u00e1, O. et al. Therapeutic effects of N-acetyl-L-cysteine on liver damage induced by long-term CCl4 administration. Gen. Physiol. Biophys. 37, 23\u201331 (2018).","journal-title":"Gen. Physiol. Biophys."},{"key":"78387_CR37","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/MEG.0b013e32834f3123","volume":"24","author":"M Galicia-Moreno","year":"2012","unstructured":"Galicia-Moreno, M., Favari, L. & Muriel, P. Antifibrotic and antioxidant effects of N-acetylcysteine in an experimental cholestatic model. Eur. J. Gastroenterol. Hepatol. 24, 179\u2013185 (2012).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"78387_CR38","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1007\/s10620-006-9717-9","volume":"52","author":"G Tahan","year":"2007","unstructured":"Tahan, G. et al. The effects of N-acetylcysteine on bile duct ligation-induced liver fibrosis in rats. Dig. Dis. Sci. 52, 3348\u20133354 (2007).","journal-title":"Dig. Dis. Sci."},{"key":"78387_CR39","first-page":"54","volume":"238","author":"GB Corcoran","year":"1986","unstructured":"Corcoran, G. B. & Wong, B. K. Role of glutathione in prevention of acetaminophen-induced hepatotoxicity by N-acetyl-L-cysteine in vivo: studies with N-acetyl-D-cysteine in mice. J. Pharmacol. Exp. Ther. 238, 54\u201361 (1986).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"78387_CR40","doi-asserted-by":"publisher","first-page":"107916","DOI":"10.1016\/j.pharmthera.2021.107916","volume":"228","author":"B Pedre","year":"2021","unstructured":"Pedre, B., Barayeu, U., Ezeri\u0146a, D. & Dick, T. P. The mechanism of action of N-acetylcysteine (NAC): the emerging role of H2S and sulfane sulfur species. Pharmacol. Ther. 228, 107916 (2021).","journal-title":"Pharmacol. Ther."},{"key":"78387_CR41","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0065-230X(08)60101-3","volume":"71","author":"D Naor","year":"1997","unstructured":"Naor, D., Sionov, R. V. & Ish-Shalom, D. CD44: structure, function, and association with the malignant process. Adv. Cancer Res. 71, 241\u2013319 (1997).","journal-title":"Adv. Cancer Res."},{"key":"78387_CR42","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fcell.2017.00018","volume":"5","author":"LT Senbanjo","year":"2017","unstructured":"Senbanjo, L. T. & Chellaiah, M. A. CD44: a multifunctional cell surface adhesion receptor is a regulator of progression and metastasis of cancer cells. Front. Cell. Dev. Biol. 5, 18 (2017).","journal-title":"Front. Cell. Dev. Biol."},{"key":"78387_CR43","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nrm1004","volume":"4","author":"H Ponta","year":"2003","unstructured":"Ponta, H., Sherman, L. & Herrlich, P. A. CD44: from adhesion molecules to signalling regulators. Nat. Rev. Mol. Cell. Biol. 4, 33\u201345 (2003).","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"key":"78387_CR44","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/nrc3023","volume":"11","author":"M Z\u00f6ller","year":"2011","unstructured":"Z\u00f6ller, M. CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? Nat. Rev. Cancer. 11, 254\u2013267 (2011).","journal-title":"Nat. Rev. Cancer"},{"key":"78387_CR45","doi-asserted-by":"crossref","unstructured":"Thanaphongdecha, P. et al. Infection with Helicobacter pylori induces epithelial to mesenchymal transition in human cholangiocytes. Pathogens. 9 (2020).","DOI":"10.1101\/2020.04.28.066324"},{"key":"78387_CR46","doi-asserted-by":"publisher","first-page":"417","DOI":"10.3389\/fcell.2020.00417","volume":"8","author":"N Suwannakul","year":"2020","unstructured":"Suwannakul, N. et al. CD44v9 induces stem cell-like phenotypes in human cholangiocarcinoma. Front. Cell. Dev. Biol. 8, 417 (2020).","journal-title":"Front. Cell. Dev. Biol."},{"key":"78387_CR47","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1186\/s12951-021-01154-2","volume":"19","author":"B Xiang","year":"2021","unstructured":"Xiang, B. et al. Single cell sequencing analysis identifies genetics-modulated ORMDL3\u2009+\u2009cholangiocytes having higher metabolic effects on primary biliary cholangitis. J. Nanobiotechnol. 19, 406 (2021).","journal-title":"J. Nanobiotechnol."},{"key":"78387_CR48","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1136\/jcp.52.10.730","volume":"52","author":"SM Cruickshank","year":"1999","unstructured":"Cruickshank, S. M., Southgate, J., Wyatt, J. I., Selby, P. J. & Trejdosiewicz, L. K. Expression of CD44 on bile ducts in primary sclerosing cholangitis and primary biliary cirrhosis. J. Clin. Pathol. 52, 730\u2013734 (1999).","journal-title":"J. Clin. Pathol."},{"key":"78387_CR49","doi-asserted-by":"publisher","first-page":"G305","DOI":"10.1152\/ajpgi.90229.2008","volume":"295","author":"Y He","year":"2008","unstructured":"He, Y. et al. Interaction of CD44 and hyaluronic acid enhances biliary epithelial proliferation in cholestatic livers. Am. J. Physiol. Gastrointest. Liver Physiol. 295, G305\u2013G312 (2008).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"78387_CR50","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1136\/gut.51.1.120","volume":"51","author":"B Xu","year":"2002","unstructured":"Xu, B., Broome, U., Ericzon, B. G. & Sumitran-Holgersson, S. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6. Gut. 51, 120\u2013127 (2002).","journal-title":"Gut"},{"key":"78387_CR51","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1002\/stem.1661","volume":"32","author":"LE Sidney","year":"2014","unstructured":"Sidney, L. E., Branch, M. J., Dunphy, S. E., Dua, H. S. & Hopkinson, A. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells. 32, 1380\u20131389 (2014).","journal-title":"Stem Cells"},{"key":"78387_CR52","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/ni.2376","volume":"13","author":"S Chiba","year":"2012","unstructured":"Chiba, S. et al. Tumor-infiltrating DCs suppress nucleic acid-mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1. Nat. Immunol. 13, 832\u2013842 (2012).","journal-title":"Nat. Immunol."},{"key":"78387_CR53","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/415536a","volume":"415","author":"L Monney","year":"2002","unstructured":"Monney, L. et al. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 415, 536\u2013541 (2002).","journal-title":"Nature"},{"key":"78387_CR54","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1126\/science.1148536","volume":"318","author":"AC Anderson","year":"2007","unstructured":"Anderson, A. C. et al. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science. 318, 1141\u20131143 (2007).","journal-title":"Science"},{"key":"78387_CR55","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/imm.12117","volume":"140","author":"M Collin","year":"2013","unstructured":"Collin, M., McGovern, N. & Haniffa, M. Human dendritic cell subsets. Immunology. 140, 22\u201330 (2013).","journal-title":"Immunology"},{"key":"78387_CR56","first-page":"3213","volume":"119","author":"MK Connolly","year":"2009","unstructured":"Connolly, M. K. et al. In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-alpha. J. Clin. Investig. 119, 3213\u20133225 (2009).","journal-title":"J. Clin. Investig."},{"key":"78387_CR57","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.bbadis.2013.01.005","volume":"1832","author":"AH Rahman","year":"2013","unstructured":"Rahman, A. H. & Aloman, C. Dendritic cells and liver fibrosis. Biochim. Biophys. Acta. 1832, 998\u20131004 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"78387_CR58","doi-asserted-by":"publisher","first-page":"1057829","DOI":"10.3389\/fphar.2022.1057829","volume":"13","author":"S Yu","year":"2022","unstructured":"Yu, S., Ji, G. & Zhang, L. The role of p53 in liver fibrosis. Front. Pharmacol. 13, 1057829 (2022).","journal-title":"Front. Pharmacol."},{"key":"78387_CR59","doi-asserted-by":"publisher","first-page":"4345","DOI":"10.1111\/bph.14035","volume":"174","author":"P Chen","year":"2017","unstructured":"Chen, P. et al. p53-mediated regulation of bile acid disposition attenuates cholic acid-induced cholestasis in mice. Br. J. Pharmacol. 174, 4345\u20134361 (2017).","journal-title":"Br. J. Pharmacol."},{"key":"78387_CR60","doi-asserted-by":"crossref","unstructured":"Yi, Y. W., You, K. S., Park, J. S., Lee, S. G. & Seong, Y. S. Ribosomal protein S6: a potential therapeutic target against Cancer? Int. J. Mol. Sci. 23, (2021).","DOI":"10.3390\/ijms23010048"},{"key":"78387_CR61","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/jcp.21172","volume":"213","author":"GK Michalopoulos","year":"2007","unstructured":"Michalopoulos, G. K. Liver regeneration. J. Cell. Physiol. 213, 286\u2013300 (2007).","journal-title":"J. Cell. Physiol."},{"key":"78387_CR62","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","volume":"149","author":"M Laplante","year":"2012","unstructured":"Laplante, M. & Sabatini, D. M. mTOR signaling in growth control and disease. Cell. 149, 274\u2013293 (2012).","journal-title":"Cell"},{"key":"78387_CR63","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s13071-017-2250-1","volume":"10","author":"L Chen","year":"2017","unstructured":"Chen, L. et al. Absence of Batf3 results in reduced liver pathology in mice infected with Schistosoma Japonicum. Parasit. Vectors. 10, 306 (2017).","journal-title":"Parasit. Vectors"},{"key":"78387_CR64","unstructured":"Single cell type\u2014BATF3\u2014The Human Protein Atlas. https:\/\/www.proteinatlas.org\/ENSG00000123685-BATF3\/single+cell+type\/liver."},{"key":"78387_CR65","doi-asserted-by":"publisher","DOI":"10.3791\/51621","author":"S Karjoo","year":"2014","unstructured":"Karjoo, S. & Wells, R. G. Isolation of neonatal extrahepatic cholangiocytes. J. Vis. Exp. https:\/\/doi.org\/10.3791\/51621 (2014).","journal-title":"J. Vis. Exp."},{"key":"78387_CR66","doi-asserted-by":"publisher","first-page":"5570","DOI":"10.1093\/hmg\/ddv289","volume":"24","author":"L Monti","year":"2015","unstructured":"Monti, L. et al. N-acetylcysteine treatment ameliorates the skeletal phenotype of a mouse model of diastrophic dysplasia. Hum. Mol. Genet. 24, 5570\u20135580 (2015).","journal-title":"Hum. Mol. Genet."},{"key":"78387_CR67","doi-asserted-by":"publisher","first-page":"7599","DOI":"10.1038\/s41598-020-64503-5","volume":"10","author":"S Fried","year":"2020","unstructured":"Fried, S. et al. Extrahepatic cholangiocyte obstruction is mediated by decreased glutathione, wnt and notch signaling pathways in a toxic model of biliary atresia. Sci. Rep. 10, 7599 (2020).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78387-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78387-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T17:02:29Z","timestamp":1730912549000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-78387-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,3]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["78387"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-78387-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,3]]},"assertion":[{"value":"3 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"26513"}}